Status:
COMPLETED
Impact of Salpingectomy on Ovarian Reserve
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Laparoscopic Salpingectomy
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Epithelial cancer of the ovaries is the most severe form of gynecologic cancer; a significant proportion of ovarian cancers originate from the Fallopian tube. Guidelines therefore now recommend system...
Eligibility Criteria
Inclusion
- Female subjects aged 18
- Scheduled surgery: bilateral laparoscopic salpingectomy associated to hysterectomy for benign indication
Exclusion
- Interview revealing disorder entailing unacceptable risk of postoperative complications: coagulation disorder, immune system disorder, evolutive disease, etc.
- Pregnancy, ongoing or planned during the study period
- History of bilateral salpingectomy
- Salpingectomy associated with pelvic cancer
- Oral hormonal contraception during the study period
- Menopause
- Inability to understand information provided
- Not covered by a national health insurance scheme, prisoner or under administrative supervision.
Key Trial Info
Start Date :
March 9 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 16 2020
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT02284711
Start Date
March 9 2015
End Date
October 16 2020
Last Update
September 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon - HFME
Lyon, France, 69003